Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism

NCT02354079 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT02354079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02354079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 7, 2016
Completion date
January 7, 2032
Enrollment
435 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypobetalipoproteinemia